Sign in
A Case of Recurrent Fixed Drug Eruption Secondary to Desloratadine
Journal article   Open access  Peer reviewed

A Case of Recurrent Fixed Drug Eruption Secondary to Desloratadine

Eman Almukhadeb
Curēus (Palo Alto, CA), Vol.13(7)
30/07/2021
PMCID: 8403490
PMID: 34476136

Abstract

General & Internal Medicine Life Sciences & Biomedicine Medicine, General & Internal Science & Technology
Desloratadine is a second-generation H1-type antihistamine that is widely prescribed for multiple indications including allergic rhinitis and urticaria. It is well-tolerated and is not known to cause cutaneous side effects including fixed drug eruption (FDE). In this report, a case of recurrent fixed drug eruption induced by desloratadine is reported.
url
https://doi.org/10.7759/cureus.16762View
Published (Version of record) Open

Metrics

1 Record Views

Details